Randomized Controlled Trial Testing a Training Program About Section 504 of the Rehabilitation Act

July 13, 2026 updated by: Meghan Burke, Vanderbilt University

Understanding and Improving Access to Section 504 Among Students With Disabilities

The goal of this training program is to learn if the intervention (i.e., training program) can improve access to Section 504 among students with disabilities and family caregivers. If students with disabilities and/or family caregivers are educated and empowered about Section 504, then there may be improved access to higher-quality of Section 504 plans. We aim to answer the following question: Is the training program effective?

If there is a comparison group: We (our research team) will compare the intervention group to a waitlist-control group to discern differences in advocacy, empowerment, and knowledge and, subsequently, higher quality Section 504 plans and greater access to services.

Participants will:

  • Attend an online class for an hour and a half each week for 6 weeks
  • Complete a pre-survey
  • Complete a formative evaluation after each program session
  • Complete a summative evaluation after the entire advocacy program
  • Complete a post-survey after completing the advocacy program
  • Complete a follow-up survey
  • Submit a copy of their child's (or their) Section 504 plan after providing consent

Study Overview

Study Type

Interventional

Enrollment (Estimated)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37203
        • Recruiting
        • It is all on zoom (so anyone in the country can join)
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria: The participant must be willing to complete the research measures and the training program as well as meet one of the two following criteria:

  • be a student aged 12-21 who receives Section 504 supports during K-12 school
  • be the caregiver of a child who receives Section 504 supports during K-12 school

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Intervention group
Treatment
Training program about Section 504 for individuals with disabilities and/or family caregivers of an individual with disabilities.
Other Names:
  • Section 504 plans
  • Section 504
Other: Waitlist-control group
Materials-only then access to advocacy training around Section 504 plans for individuals with disabilities and/or family caregivers of individuals with disabilities. Will have advocacy training 6 months after the control group.
Other Names:
  • Section 504 plans
  • Section 504

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge of Section 504
Time Frame: From enrollment to the end of the training program at six weeks
This is a 20 item measure; each item has four response options. Only one response option is correct. The score is the sum of correct responses ranging from 0 to 20.
From enrollment to the end of the training program at six weeks
Advocacy Activities Scale
Time Frame: From enrollment to the end of the training program at six weeks
This is a 15 item measure wherein each item has four response options. The final score is the sum of the response options.
From enrollment to the end of the training program at six weeks
Empowerment
Time Frame: From enrollment to the end of the training program at six weeks
This is a 34 item measure wherein each item has four responses. The score is the sum of the responses.
From enrollment to the end of the training program at six weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of the Section 504 plan
Time Frame: From enrollment to six months after the end of the training program
This is a rubric which gauges the quality of the Section 504 plan. The score reflects a range from 0-15 of needed items on the Section 504 plan.
From enrollment to six months after the end of the training program
Service access
Time Frame: From enrollment to six months after the end of the training program
This is a 24 item measure that examines whether a certain support is received. The score is the sum of received supports (ranging from 0-24).
From enrollment to six months after the end of the training program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2026

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

September 1, 2028

Study Registration Dates

First Submitted

July 13, 2026

First Submitted That Met QC Criteria

July 13, 2026

First Posted (Actual)

July 17, 2026

Study Record Updates

Last Update Posted (Actual)

July 17, 2026

Last Update Submitted That Met QC Criteria

July 13, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 90DPGE0101 (Other Grant/Funding Number: National Institute on Disability, Independent Living, and Rehabilitation Research)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The de-identified data may be uploaded to the Interuniversity Consortium for Political and Social Research (ICPSR).

IPD Sharing Time Frame

At the conclusion of the project for an indefinite period of time.

IPD Sharing Access Criteria

Anyone can access the data at ICPSR.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Students With Disabilities and/or Family Members With Students With Disabilities That Have a Section 504 Plan

  • China Medical University Hospital
    Yueh Ling Hsieh's laboratory funding
    Completed
    Physical Fitness Performance of Students With Physical and Mental Disabilities | Physical Therapy Technology Integrated Into Physical Education Curriculum
    Taiwan
  • University of Sao Paulo
    Santander
    Terminated
    Inclusion Criteria: | Voluntary Participation in the Study With Available Time for Submission to the Sessions, Which Occur Over Two Months. | Have a Score of Stress Medium, High or Very High in the LSS Questionnaire, Completion of the STAI and General Form. | Exclusion Criteria: | Pregnant...
  • University of California, San Francisco
    University of California, Davis
    Not yet recruiting
    Participants Must be Women Aged 25 Years or Older | Participants Should Have no Self-reported History of Heart Disease or Stroke | Participants Should Have no Terminal Illness or Diagnosed Cognitive Impairment, Including Alzheimer's Disease | Participants Should Not be a Healthcare Professionals... and other conditions
    United States

Clinical Trials on Treatment

3
Subscribe